Filter By Category
Archives
Share on -
ACROCINONIDE
Generic Name: ACROCINONIDE
ABSTRACT -
Acrocinonide is an investigational corticosteroid compound being studied for anti-inflammatory applications. Like other corticosteroids, it is expected to act by binding to glucocorticoid receptors and modulating inflammatory gene expression. It is under research for topical or systemic use in inflammatory conditions.
DOSAGE -
Acrocinonide is an investigational compound. Dosage and route of administration are defined by clinical trial protocols. No established approved dosing for routine clinical use.
SIDE EFFECTS –
Reported or potential side effects may include:
- Skin thinning (topical use)
- Local irritation
- Hypopigmentation
- Adrenal suppression (systemic use)
- Elevated blood glucose
- Fluid retention
ALLRGIC REACTIONS–
-
(These symptoms may indicate an allergic reaction to the drug.)
- Contact dermatitis
- Hypersensitivity to corticosteroid components
- Urticaria
- Angioedema
DRUG INTERACTIONS–
- Other corticosteroids (additive effects)
- CYP3A4 inhibitors (increased steroid exposure)
- Diuretics (electrolyte imbalance)
- Antidiabetic agents (blood glucose effect)
- NSAIDs (GI risk)
PREAUTIONS–
- Avoid prolonged use on face or intertriginous areas.
- Gradual tapering required to avoid adrenal insufficiency.
- Monitor blood glucose in diabetic patients.
- Safety in pregnancy and breastfeeding not fully established.
- Avoid contact with eyes.
WARNINGS –
- Prolonged corticosteroid use associated with Cushing's syndrome.
- Risk of HPA axis suppression.
- Not for ophthalmic use unless specified.
- Keep out of reach of children.
- Report signs of infection during therapy.
Share on -
. Developed by